Cabot Corporation (CBT) is a premier global specialty chemicals and performance materials company, recognized for its innovative solutions that elevate performance, sustainability, and safety in diverse applications across industries such as tire, plastics, coatings, and electronics. The company specializes in carbon black, recovery solutions, and specialty compounds, underpinned by strong research and development capabilities that foster continuous innovation. With a commitment to operational excellence and environmental sustainability, Cabot Corporation seeks to minimize its ecological footprint while maximizing performance outcomes, reinforcing its status as a trusted partner in advanced materials and a leader in sustainable practices.
170 articles
Cabot Corporation is scheduled to report Q4 2026 earnings on November 2nd, with analysts expecting $1.55 EPS and $927.29 million in revenue. The specialty chemicals firm previously exceeded estimates
Cabot Corporation submitted a Form 4 regulatory filing disclosing insider trading activity by Senior Vice President William F. Masterson III dated September 30.
Cabot Corporation disclosed insider trading activity via Form 4 filing by SVP and General Counsel Karen A. Kalita for the period ending September 30.
Cabot Corporation filed a Form 4 disclosing stock transactions by CEO Sean D. Keohane for the period ending September 30. This regulatory filing details insider trading activities within the specialty
Karen A. Kalita, Senior Vice President and General Counsel of Cabot Corp, filed a Form 4 with the SEC on September 30 regarding material changes in holdings.
Argus Research lowered its price target for Cabot Corporation (CBT) to $73.00, while the stock currently trades at $74.70. The report provides quantitative analysis for the chemical and materials manu
Cabot Corporation will announce its fourth-quarter fiscal 2026 operating results on November 2, 2026, followed by a conference call on November 3. Investors can access the webcast via the company's in
Cabot Corporation will release its fourth-quarter fiscal 2026 operating results after market close on November 2, 2026. A conference call and webcast will be held on November 3 at 8:00 AM ET.
Argus Research lowered its price target for Cabot Corporation (CBT) to $73.00, while the stock currently trades at $74.91. The company specializes in manufacturing and selling various chemicals and ma
Argus Research lowered its price target for chemical manufacturer Cabot Corporation (CBT) to $73.00, below the current stock price of $75.61. The company produces a range of chemicals, materials, and
Cabot Corporation Interim CFO Steven J. Delahunt disclosed his share holdings, including 5,399 direct common shares and phantom stock units, effective October 1, 2026.
Cabot Corporation held its Q2 FY2026 earnings call on May 6, 2026, featuring remarks from VP of Investor Relations Robert Rist. The full transcript archive is accessible via a premium subscription on
Wall Street Zen downgraded Cabot Corporation to 'Hold' from 'Buy,' aligning with consensus despite Q3 earnings beating estimates with $982 million revenue.
Cabot Corporation received a consensus 'Hold' rating with an $89 price target after beating Q2 EPS estimates and growing revenue 6.4% year-over-year. The CEO sold $11.5 million in shares while the com
Cabot Corporation CFO Erica McLaughlin received 93.54 phantom stock units valued at $76.91 per share under the supplemental 401(k) plan, increasing her total holdings to 10,455.61 units.
Cabot Corporation's SVP and General Counsel acquired 44.8795 Phantom Stock Units valued at $76.91 each under the company's supplemental 401(k) plan on September 30, 2026.
Cabot Corporation President and CEO Sean D. Keohane acquired 346 phantom stock units via the company's supplemental 401(k) plan on September 30, 2026, raising his total holdings to over 48,000 units.
Cabot Corporation's 7.28% bond maturing October 21, 2027 is profiled, detailing issue dates, face value, and interest payment schedules.
Cabot Corporation, a global specialty chemicals and performance materials company, has released a detailed profile for its CBT4847793 bond. The document outlines key terms including a 4.00% semi-annua
Cabot Corporation bond CBT6483410 features a 4.95% coupon rate maturing August 15, 2029, with defined face value and redemption terms.
Cabot Corporation reported a 4% sequential increase in adjusted EPS to $1.67 for Q3 2026, appointing Erica McLaughlin as new CEO. The company emphasized battery materials growth and tightened fiscal 2
State Street Corp increased its Cabot Corporation stake by 6.8% to $196.66 million in Q2, while Cabot reported strong earnings beating revenue estimates despite significant insider sales totaling over
Cabot Corporation will expand domestic production of advanced conductive additives using a $50 million DOE grant and $75 million investment. Projects in Louisiana and Texas aim to meet energy storage
Cabot Corporation invests $125 million plus a $50 million DOE grant to expand domestic production of advanced conductive additives in Louisiana and Texas by 2028. The move strengthens the U.S. battery
Bank of America Corp acquired 1.66 million shares of specialty chemical firm Cabot Corporation worth $150.8 million, raising its stake to 3.22%. Cabot recently exceeded earnings estimates with $1.67 E
Cabot Corporation will expand its North American battery materials platform using a modified $50 million DOE grant combined with $75 million in company investment. The project aims to boost domestic p
Cabot Corporation secured a $50 million U.S. Department of Energy grant to expand its battery materials platform alongside a $75 million private investment. Production of advanced conductive additives
Cabot Corp VP Lisa Dumont received 4,403.9 phantom stock units under the Supplemental 401(k) Plan, to be settled in shares upon retirement.
Cabot Corporation director Douglas G. DelGrosso was granted 30,628 phantom stock units on September 11, 2026, raising his total holdings to 5,195 units. The grant was made under the company's deferral
Cabot Corp CEO Sean D. Keohane received 283.6 phantom stock units on September 11, 2026, bringing his total holdings to over 48,000 units, which convert to common stock upon retirement.
ChemBrief